off-label use News
Most Popular off-label use Story
Genentech: Avastin linked to eye inflammation
In something of a vindication for Genentech, the company announced 36 reports of inflammatory responses in Canadian patients using Avastin for the off-label treatment of wet age-related macular... Read more...
Latest Headlines
- August 24, 2009
- December 22, 2008
- December 3, 2008
- November 25, 2008
- November 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
